AGIOS PHARMACEUTICALS, INC. Treasury Stock, Common, Shares
AGIOS PHARMACEUTICALS, INC. (AGIO) had Treasury Stock, Common, Shares of 16.22 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-07-30
- 2026-06-30: Treasury Stock, Common, Shares 16.22M shares.
- 2026-03-31: Treasury Stock, Common, Shares 16.22M shares.
- 2025-12-31: Treasury Stock, Common, Shares 16.22M shares.
- 2025-09-30: Treasury Stock, Common, Shares 16.22M shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-06-30 | 16.22M shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 16.22M shares 10-Q · filed 2026-04-29 |
| 2025-12-31 | 16.22M shares 10-Q · filed 2026-07-30 |
| 2025-09-30 | 16.22M shares 10-Q · filed 2025-10-30 |
| 2025-06-30 | 16.22M shares 10-Q · filed 2025-07-31 |
| 2025-03-31 | 16.22M shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 16.22M shares 10-K · filed 2026-02-12 |
| 2024-09-30 | 16.22M shares 10-Q · filed 2024-10-31 |
| 2024-06-30 | 16.22M shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 16.22M shares 10-Q · filed 2024-05-02 |
| 2023-12-31 | 16.22M shares 10-K · filed 2025-02-13 |
| 2023-09-30 | 16.22M shares 10-Q · filed 2023-11-02 |
| 2023-06-30 | 16.22M shares 10-Q · filed 2023-08-03 |
| 2022-12-31 | 16.22M shares 10-K · filed 2024-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |